Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Construction method and application of transgenic animal with blood-brain barrier permeability enhanced

A technology for transgenic animals and blood-brain barrier, which is applied in the field of construction of transgenic animal models, can solve the problems of inability to stably open the blood-brain barrier and restrict the development of drugs in the central nervous system.

Inactive Publication Date: 2013-11-27
GUANGDONG PHARMA UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Studies have shown that in the treatment of intracranial diseases, focused ultrasound can not only ablate the blood-brain barrier, but also partially open the blood-brain barrier, but it still cannot open the blood-brain barrier stably.
[0014] Although there are many ways to open the blood-brain barrier at present, there are problems in varying degrees, such as safety, targeting, tissue compatibility, etc., which seriously restrict the development of central nervous system drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of transgenic animal with blood-brain barrier permeability enhanced
  • Construction method and application of transgenic animal with blood-brain barrier permeability enhanced
  • Construction method and application of transgenic animal with blood-brain barrier permeability enhanced

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] Slit is an extracellular matrix secreted protein. It was discovered in Drosophila by Nusslein Volhard et al. in 1984. The encoded gene is 4p15.2. Its main function is to guide the direction of axon formation during the development of the central nervous system And the migration of nerve cells, and participate in the proliferation, apoptosis, adhesion and migration of non-neural cells during the formation of organs. Current studies have confirmed that the Slit protein family in mammals has three subtypes (Slit1, Slit2, and Slit3), which share 60% homology. Slit1 is only expressed in nerve tissue; Slit2 is distributed in nerve tissue, kidney, lung and endothelial cells; Slit3 is localized in mitochondria, mainly in lung tissue, and also in kidney, brain, heart, spleen and lymph nodes. The Slit protein consists of an N-terminal signal peptide, four consecutive leucine-rich repeat LRRs, and nine EGF-like functional regions (such as figure 1 ). The LRR repeats are required...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a construction method and an application of a transgenic mouse with blood-brain barrier permeability enhanced. The construction method of the transgenic mouse with blood-brain barrier permeability enhanced comprises the step of modifying genes of a mouse, so that expression quantity of slit protein is increased, and a transgenic animal model with blood-brain barrier permeability enhanced is obtained; Study shows that overexpression of slit protein can cause that a tricorn of the mouse is enlarged, a choroid plexus structure is seriously destroyed, and tight junction of epithelium cells is lost; observation on a vascular structure of the brain of a Slit-Tg mouse by virtue of immunofluorescent staining shows that bifurcation of blood vessels of the brain of the Slit-Tg mouse is less, more microvessels exist, the shapes of vessels are incomplete and the distribution of the vessels is irregular; a transmission electron microscope map also shows that endothelial cells of the Slit-Tg mouse are damaged and highly irregular and basement membranes of vessels are incomplete. Evansblueassay detects that the permeability of the mouse is enhanced, i.e., the detection result shows that the blood-brain barrier permeability of the Slit-Tg mouse is enhanced, the Slit-Tg mouse can be applied to an animal experiment of central nervous system drugs and the Slit-Tg mouse can be used for screening, research and development as well as therapeutic effect evaluation on nervous system drugs.

Description

Technical field [0001] The present invention involves the construction method and application of a genetically modified animal model, and specially involves the construction method and application of a genetically modified animal model with increased permeability of the blood -brain barrier. Background technique [0002] The central nervous system is the strictest and sensitive system of the human body.Normal nerve function requires a highly strict extracellular environment. The concentration of sodium, calcium, and potassium needs to be limited to a very narrow range.In addition, the metabolic demand of the nervous system is very strong, and its consumption of 20%of human oxygen consumption. [0003] The nervous system is very sensitive to many chemicals. Many of the substances in daily diet, although it has no harm to other organs, is neurotoxic, so there is a interface between the peripheral circulation system and the central nervous system of the mammalian body., To dynamical...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85G01N33/15
Inventor 王丽京李江超亓翠玲韩露温寅鑫
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products